Townson Sharon sold GLUE
July 6, 2026 · Form 4 insider transaction
Townson Sharon sold 400 shares of Monte Rosa Therapeutics, Inc. at $24.13 per share, a transaction worth $9.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
400
Price
$24.13
Total value
$9.7K
InsiderTownson Sharon
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 6, 2026
Filing dateJuly 7, 2026
Shares owned after67,845
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026.